Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Comparison of Blood Pressure Medications on Metabolism [Phase 4]
Phase 4 trial comparing blood pressure medications and their metabolic effects in diabetes; results posted after completion.
-
FDA approval · 2023-12-22FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)
The FDA approved a supplemental application to add the Gvoke Hypopen 0.5 mg auto-injector for glucagon injection solution. This expands the …
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety [Phase 3]
Phase III study completed evaluating the efficacy and safety of insulin aspart injection for diabetes.
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2 [NA]
Clinical trial update on determinants of alpha-aminoadipic acid (2-AAA) and its relationship to diabetes; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Long-term Study of SYR-472 [Phase 3]
A long-term Phase 3 clinical trial update for SYR-472 in diabetes mellitus has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus [Phase 4]
Phase 4 trial update evaluating pharmacokinetics of switching from twice-daily tacrolimus to once-daily extended-release tacrolimus in diabe…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Double-blind Comparative Study of SYR-472 [Phase 3]
Phase 3 double-blind comparative study of SYR-472 in diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: SYR-472 Open-label Study [Phase 3]
An open-label Phase 3 clinical trial update for SYR-472 in diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass [Phase 2]
A Phase 2 GLP-1 receptor PET imaging substudy within the VER-A-T1D trial evaluates the effects on beta cell mass in diabetes patients.
-
EMA approval · 2023-12-06EMA Authorised: Amglidia (glibenclamide) — Ammtek
Amglidia (glibenclamide) has been authorised in the EU for diabetes mellitus as an orphan medicine.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema [Phase 2]
Phase 2 trial evaluating THR-149 for diabetic macular edema has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Telemedicine for Reach, Education, Access and Treatment-ongoing [NA]
A clinical trial investigating telemedicine for reach, education, access, and treatment in diabetes mellitus was terminated; results posted …
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain [Phase 2]
Phase 2 trial updates safety and efficacy of BAY2395840 in diabetic neuropathic pain due to diabetic peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Dexcom G6 Intervention Study [NA]
Clinical trial update for the Dexcom G6 intervention study completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral Neuropathy [Phase 2]
A Phase 2 clinical trial comparing topical pirenzepine to placebo in patients with painful diabetic neuropathy (type 2 diabetes) has complet…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Transdermal Insulin Response In Healthy Volunteers [EARLY_Phase 1]
Early-phase 1 clinical trial results assessing pharmacodynamic response to small doses of insulin via a transdermal delivery system in healt…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes [Phase 2]
A Phase 2 trial evaluating intravenous immunoglobulin therapy for treatment-induced diabetic neuropathy was terminated, and results have bee…
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: IDegLira HIGH Trial [Phase 3]
A Phase 3 clinical trial updating on IDegLira HIGH showed completed status with results posted in 2023, involving diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Evaluation of a Letter Intervention Promoting a Plant-based Diet [NA]
Geisinger Clinic completed a trial evaluating a letter intervention promoting a plant-based diet and has posted results, targeting cardiovas…
-
FDA approval · 2023-08-31FDA Approved: ADMELOG — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA granted approval of a supplemental application for ADMELOG (insulin lispro) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322 [Phase 4]
A Phase 4 double-blind study evaluating coadministration of AD-4833 and SYR-322 in diabetes mellitus; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Continuous Glucose Monitoring During and After Surgery [NA]
A completed clinical trial evaluating continuous glucose monitoring during and after surgery in patients with diabetes.
-
EMA approval · 2023-08-29EMA Authorised: NovoMix (insulin aspart) — Novo Nordisk A/S
NovoMix (insulin aspart) by Novo Nordisk A/S has been authorised for use in the European market for diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals [Phase 1, Phase 2]
A clinical trial update on oral 6-bromotryptophan assessing safety, pharmacokinetics, and efficacy in metabolic syndrome and diabetes mellit…
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. [Phase 2]
Phase 2 trial update for THR-687 in diabetic macular edema was terminated; results posted in 2023.